Hereditary breast and ovarian cancer

Nodira I. Tursunova, Dilbar M. Almuradova, Khadicha Kh. Turayeva, Dilsora I. Mukimovaю

dc.contributor.author	Nodira I. Tursunova, Dilbar M. Almuradova, Khadicha Kh. Turayeva, Dilsora I. Mukimovaю
dc.date.accessioned	2022-10-12T14:10:41Z
dc.date.available	2022-10-12T14:10:41Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/3801
dc.description.abstract	Prevalence of germline BRCA mutations has been estimated to be about 1:1,600 women in the general population. Rate of BRCA1/2 mutations in Ashkenazi Jews population is 98-99%. Rate of BRCA1/2 mutations in Russian population is high – 28.4%. The average woman's lifetime risk of developing breast cancer is about 12%. In women with the BRCA1 mutation, the risk rises to about 72%, and in women with the BRCA2 mutation, to about 69%. They are also at a higher risk of getting cancer of a second breast after the first - the risk of developing contralateral breast cancer is about 40%.	en_US
dc.language.iso	other	en_US
dc.publisher	Other	en_US
dc.subject	Hereditary breast and ovarian cancer , BRCA1/2 mutations, genetic test.	en_US
dc.title	Hereditary breast and ovarian cancer	en_US
dc.type	Article	en_US